Francisco Partners to Sell Medication Management Company Aesynt to Omnicell
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Omnicell, Inc. (NASDAQ: OMCL) | Delayed: 37.52 +0.42 (1.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.10 | 52 Week High | $40.50 | |||
| Open | $36.87 | 52 Week Low | $25.06 | |||
| Day High | $37.64 | P/E | 56.00 | |||
| Day Low | $36.60 | EPS | $0.67 | |||
| Volume | 453,906 | |||||
